MUTABILIS
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives. Mutabilis is a biopharmaceutical company specialised in the discovery and development of anti-infectives. Mutabilis discovers and develops innovative anti-infectives, a novel class of drug addressing the current issues arising from resistance to antibiotics and targeting severe bacterial infections. Mutabilis’ new therapies target nosocomial infections in particular.
MUTABILIS
Industry:
Biotechnology
Founded:
2001-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.en.mutabilis.fr
Total Employee:
11+
Status:
Active
Contact:
+33 1 57 14 05 20
Total Funding:
14.24 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Font Awesome Domain Not Resolving Apache
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Mutabilis
Repair Impact Fund
Repair Impact Fund investment in Venture Round - Mutabilis
Omnes Capital
Omnes Capital investment in Venture Round - Mutabilis
More informations about "Mutabilis" on Search Engine
Mutabilis
Mutabilis is a biopharmaceutical company developing novel-class antibacterials to treat life-threatening infection caused by WHO Priority 1 / Critical pathogens: Carbapenem-resistant Acinetobacter baumannii. …See details»
Mutabilis | LinkedIn
Mutabilis is a privately-held French biopharmaceutical company developing novel non-beta-lactam PBP-targeting antibacterial drugs called dabocins to treat the most difficult-to-treat...See details»
CARB-X is funding French biotech Mutabilis to develop a …
(BOSTON: February 3, 2021) – CARB-X is awarding Mutabilis, a biopharmaceutical firm based in Romainville, France, up to US$6.4 million to develop a new drug to treat …See details»
Mutabilis - Products, Competitors, Financials, …
Mutabilis is a biopharmaceutical company focused on the development of novel-class antibacterials for the treatment of life-threatening infections caused by critical pathogens.See details»
From model organism to application: Bacteria-induced …
Jan 30, 2023 The macroalga Ulva mutabilis was established as a model system in chemical ecology. Cross-kingdom interactions foster symbiosis between Ulva and …See details»
Mutabilis Press
The Mutable Hour. Our seasonal poetry readings, The Mutable Hour, have been a great hit bringing together national and international poets. The next installment of our online reading series on Wednesday, December 13 …See details»
Kuehneromyces mutabilis - Wikipedia
Description. The clustered shiny convex caps are 6–8 cm in diameter. They are very hygrophanous; in a damp state they are shiny and greasy with a deep orange-brown …See details»
Figeater beetle - Wikipedia
Cotinis mutabilis, also known as the figeater beetle (also green fruit beetle or fig beetle ), is a member of the scarab beetle family. It belongs to the subfamily Cetoniinae, comprising …See details»
Growth and Thallus Morphogenesis of Ulva mutabilis …
Sep 11, 2012 Abstract. Axenic Ulva mutabilis gametes develop parthenogenetically into callus-like colonies consisting of undifferentiated cells without normal cell walls. From the …See details»
Streptomyces mutabilis - Wikipedia
Streptomyces mutabilis is a bacterium species from the genus of Streptomyces which has been isolated from soil. [1] [2] [3] [4] [5] Streptomyces mutabilis produces the antibiotic …See details»
Macroalgal–bacterial interactions: identification and role of …
Feb 4, 2020 Under axenic conditions, the macroalga Ulva mutabilis develops a callus-like phenotype with cell wall protrusions. However, co-culturing with Roseovarius sp. (MS2) …See details»
☑️Mutabilis — Consulting Organization from France, …
Mutabilis — Consulting Organization from France, has experience with The Seventh Framework Programme, it`s involved in Health, Science & Innovation sectorsSee details»
Lupinus mutabilis: Composition, Uses, Toxicology, and Debittering
Jul 3, 2016 Lupinus mutabilis has protein (32.0-52.6 g/100 g dry weight) and lipid (13.0-24.6 g/100 g dry weight) contents similar to soya bean (Glycine max). The Ω3, Ω6, and …See details»
Lupinus mutabilis - Wikipedia
Lupinus mutabilis is a species of lupin grown in the Andes, mainly for its edible bean. Vernacular names include tarwi (in Quechua II, [2] pronounced tarhui ), chocho, …See details»
Biology | Free Full-Text | Transcription and Metabolic Profiling
Aug 10, 2023 In this study, we used combined transcriptomics and metabolomics to analyze the H. mutabilis cultivar’s genetic and physiological mechanisms during three …See details»
Oikomonas mutabilis - GBIF
A manual of the infusoria, including a description of all known flagellate, ciliate, and tentaculiferous protozoa, British and foreign and an account of the organization and …See details»
Mutabilis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Mutabilis is discovery of new therapeutic targets for the development of anti-infectives.See details»
Aiptasia mutabilis - Wikipedia
Aiptasia mutabilis, also known as the Trumpet anemone, Rock anemone, and Glass anemone, [1] is a species of anemone typically found attached to substrates in cold …See details»
YGOrganization | Yu-Gi-Oh! news that ends misinformation
1 day ago YGOrganization is the world’s most reliable information source for all Yu-Gi-Oh! news and content.See details»